TrialAntimicrobial agents and chemotherapy2018

A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study).

Thomas L Holland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.